Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03431818 · ClinicalTrials.gov registry record
Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 35
- Enrollment target
NCT03431818: Completed study, sponsored by University of Miami.
NCT03431818 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03431818 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (NC-FiO2), NC flow rate, spontaneous minute ventilation and other patient characteristics in premature infants who receive supplemental oxygen via nasal cannula (NC).
Primary Outcome
FiO2 necessary to maintain the effective FiO2 (measured at the hypopharynx) at the basal level at different nasal cannula flow rates.
Interventions
- OTHER Nasal cannula flow rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2023-09-07 |
What the finished NCT03431818 record still lists
NCT03431818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nasal cannula flow rate is the first listed.
NCT03431818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03431818 about?
NCT03431818 is a clinical study titled "Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants". The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (NC-FiO2), NC flow rate, spontaneous minute ventilation and other patient characteristics in premature...
What is the current status of trial NCT03431818?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2018-04-04. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT03431818?
The interventions under investigation include: Nasal cannula flow rate (OTHER).
Who is sponsoring clinical trial NCT03431818?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI